Ferroptosis as a potential therapeutic target for age-related macular degeneration

Dongcheng Liu1, Ziling Liu1, Hongxia Liao1

  • 1Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China; Shenzhen Aier Ophthalmic Technology Institute, Shenzhen, China.

Drug Discovery Today
|February 18, 2024
PubMed

Insights

Ferroptosis, a form of cell death involving iron and lipid peroxides, is key in age-related macular degeneration (AMD) progression. Inhibiting ferroptosis shows promise for treating AMD by protecting retinal cells.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pathogenesis of Age-Related Macular Degeneration

Background:

  • Cell death is integral to age-related macular degeneration (AMD) pathogenesis, but mechanisms are not fully understood.
  • Emerging evidence implicates ferroptosis, an iron-dependent cell death pathway marked by lipid hydroperoxide accumulation, in AMD.
  • Ferroptosis contributes to retinal cell degradation and accelerates AMD progression.

Purpose of the Study:

  • To review the molecular mechanisms of ferroptosis in AMD.
  • To identify potential ferroptosis inhibitors for AMD treatment.
  • To discuss challenges and opportunities in targeting ferroptosis therapeutically for AMD.

Main Methods:

  • Literature review of studies on ferroptosis and AMD.
  • Analysis of molecular pathways involved in ferroptosis.
  • Evaluation of existing and potential ferroptosis inhibitors.

Main Results:

  • Ferroptosis is a significant contributor to retinal cell death in AMD.
  • Inhibitors of ferroptosis demonstrate protective effects in AMD models.
  • Targeting ferroptosis presents a promising therapeutic avenue for AMD.

Conclusions:

  • Ferroptosis is a critical mechanism driving retinal cell death in AMD.
  • Therapeutic strategies targeting ferroptosis could offer new treatments for AMD.
  • Further research is needed to overcome challenges in clinical applications of ferroptosis inhibitors.